Maintenance of routine performance Studies with Epithalon focus on preserving everyday function rather than enhancing peak output
Sharma P, Kumar A, Sharma BC, Sarin SK
Why "GLP-1 patches" is misleading This is where the marketing gets particularly slippery, and it's worth understanding before you part with any money
At a 5mg/ml concentration, 0.25mg equals 5 units on a standard U-100 insulin syringe
16 Figure 3: Risk of OACs in patients on GLP-1s versus patients on insulin Conclusion GLP-1s, initially developed to help manage and treat diabetes and later used to treat obesity, are now showing significant potential to help prevent and treat CVD, mental health disorders, liver and kidney disorders, neurodegenerative disorders, addiction disorders, and cancer